InspireMD (NSPR) Convertible Debt (2010 - 2012)

InspireMD (NSPR) posted quarterly Convertible Debt of $5.6 million for Q3 2012, up 12.3% quarter-over-quarter from $5.0 million in Q2 2012.

InspireMD (NSPR) Convertible Debt (2010 - 2012) Analysis & Trends

InspireMD's Convertible Debt history runs 2 years deep, the most recent figure standing at $5.6 million for Q3 2012.

In Q3 2012, Convertible Debt changed N/A year-over-year to $5.6 million; the TTM figure through Sep 2012 stood at $5.6 million (changed N/A YoY), while the FY2012 annual figure was $5.0 million, changed N/A from the prior year.
Convertible Debt for Q3 2012 stood at $5.6 million, up from $5.0 million in the prior quarter.
The five-year high for Convertible Debt was $5.6 million in Q3 2012, with the low at $1.0 million in Q4 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn
10	InspireMD	58.54 Mn	4.33 Mn	1.18 Mn

Download Data